Daily Ards Research Analysis
New mechanistic and preclinical ARDS studies highlight exosome-mediated macrophage reprogramming and a standardized long-lasting rat hyperoxia model with radiomic readouts, while an obstetric cohort clarifies neonatal mortality risks after PPROM. Together, these works advance pathophysiology understanding, provide a robust translational platform, and inform perinatal risk stratification.
Summary
New mechanistic and preclinical ARDS studies highlight exosome-mediated macrophage reprogramming and a standardized long-lasting rat hyperoxia model with radiomic readouts, while an obstetric cohort clarifies neonatal mortality risks after PPROM. Together, these works advance pathophysiology understanding, provide a robust translational platform, and inform perinatal risk stratification.
Research Themes
- Exosome-based immunomodulation in ARDS
- Standardized preclinical ARDS modeling with imaging/radiomics
- Perinatal risk stratification after PPROM
Selected Articles
1. hnRNPA2B1 promotes the production of exosomal miR-103-3p from endothelial progenitor cells to alleviate macrophage M1 polarization in acute respiratory distress syndrome.
EPC-derived exosomes deliver miR-103-3p, sorted via hnRNPA2B1, to macrophages where it targets TLR4, suppresses NF-κB, promotes M2 and attenuates M1 polarization, reducing lung inflammation in ARDS models. Knockdown of miR-103-3p abolishes these effects, underscoring a specific hnRNPA2B1–miR-103-3p–TLR4 axis.
Impact: Identifies a tractable exosome–microRNA pathway that reprograms macrophage polarization in ARDS, revealing hnRNPA2B1 as a regulator of therapeutic cargo loading. This advances mechanistic understanding and suggests a novel immunomodulatory strategy.
Clinical Implications: Supports development of EPC-exosome or miR-103-3p–based therapies and TLR4/NF-κB–targeted approaches to modulate macrophage phenotypes in ARDS.
Key Findings
- EPC-derived exosomes transfer to macrophages and modulate LPS-induced polarization.
- miR-103-3p is enriched in EPC exosomes, directly targets TLR4 3'-UTR, and suppresses TLR4/NF-κB signaling.
- miR-103-3p overexpression promotes M2 and suppresses M1 polarization; knockdown abrogates exosome effects in vitro and in vivo.
- hnRNPA2B1 interacts with miR-103-3p and mediates its exosomal secretion.
Methodological Strengths
- Multi-assay mechanistic validation (dual-luciferase, RNA pull-down, RIP) with in vitro and in vivo ARDS models.
- Direct cargo tracking (PKH-26) and pathway dissection of TLR4/NF-κB.
Limitations
- Preclinical mouse and cell-line models; no human validation.
- Dosing, biodistribution, and safety of exosome delivery are not addressed.
Future Directions: Test human primary macrophages and ARDS patient samples, optimize exosome delivery, and evaluate efficacy/safety in large-animal models.
BACKGROUND: Macrophage polarization plays a crucial role in acute respiratory distress syndrome (ARDS). Recently, mounting evidence has uncovered that endothelial progenitor cells (EPCs) secreted exosomes (EPCs-Exos) exert obvious therapeutic effects on the pathological inflammatory process of ARDS, but its potential mechanism is rarely reported. METHODS: The primary mouse EPCs and EPCs-Exos were isolated and identified. Absorption of EPCs-Exos by RAW264.7 cells was examined by PKH-26 staining. The polarization of RAW264.7 cells was evaluated by flow cytometry and RT-qPCR analysis. Molecular interactions were verified by dual luciferase assay, RNA pull-down and RNA immunocoprecipitation assays. ARDS mouse model was established, and pathological changes and expressions of related molecules were detected by HE staining, RT-qPCR and western blotting. RESULTS: EPCs-Exos could be transferred to macrophages, and effectively reversed LPS-induced polarization of macrophages from M2 to M1 phenotype; however, these changes were diminished by activation of TLR4/NF-κB pathway. MiR-103-3p was proved to be enriched in EPC-Exos and could transfer to macrophage and inactivating TLR4/NF-κB pathway via directly binding to TLR4 3'-UTR. Moreover, miR-103-3p overexpression elevated macrophage M2 polarization and repressed M1 polarization in LPS-treated cells by inhibiting TLR4/NF-κB pathway, and knockdown of miR-103-3p in EPC-Exos abolished the regulatory roles of EPC-Exos on macrophage polarization in vitro, and lung inflammatory injury in vivo. HnRNPA2B1 was proved to interact with miR-103-3p and responsible for its exosomal secretion, which repressed pro-inflammatory macrophage polarization. CONCLUSION: These findings suggested that hnRNPA2B1-mediated exosomal delivery of miR-103-3p from EPCs protected against macrophage inflammation in ARDS by inactivation of TLR4/NF-κB pathway.
2. A long-lasting rat model of hyperoxia-induced acute respiratory distress syndrome: Systematic evaluation and validation.
A standardized hyperoxia-induced rat ARDS model reproduces key clinical-pathological features, including Berlin-defined oxygenation impairment, hyaline membranes, barrier leak, cytokine surge, and diffuse micro-CT changes with radiomic signatures. The model shows sustained, severity-controllable injury and supports evaluation of ventilatory and pharmacologic interventions.
Impact: Provides a robust, reproducible, and long-lasting ARDS model with imaging and radiomic readouts, addressing a key translational gap between basic and clinical research.
Clinical Implications: Enables preclinical testing of ventilatory strategies and anti-inflammatory/anti-fibrotic therapies in a model that captures clinically relevant ARDS features.
Key Findings
- 95% O2 exposure in rats induces Berlin-defined mild–moderate ARDS-level oxygenation impairment by 48 h (p < 0.0001).
- Histology shows hyaline membranes, increased alveolar–capillary permeability, and robust inflammation (TNF-α, IL-1β, IL-6; all p < 0.0001).
- Micro-CT demonstrates diffuse injury with severity progression and radiomic features analogous to human ARDS (p < 0.01).
- Injury is long-lasting and severity-controllable; assisted ventilation experiments validate model properties over 7 days.
Methodological Strengths
- Standardized protocol with multi-timepoint physiological, histological, and molecular assessments.
- Integrated micro-CT and radiomic analysis plus ventilation challenge for functional validation.
Limitations
- Hyperoxia model may not capture sepsis/aspiration-mediated ARDS etiologies.
- Single sex (male) rats; external validity and fibrosis resolution dynamics need further study.
Future Directions: Benchmark against infectious and aspiration ARDS models, include both sexes/ages, and use the platform to test ventilatory protocols and candidate drugs.
Acute respiratory distress syndrome (ARDS) is an acute diffuse inflammatory lung injury with high morbidity and mortality. Existing animal models fail to replicate all features of human ARDS pathophysiology. This study aimed to establish a standardised protocol for creating a rat model of hyperoxia-induced ARDS, assess the model's compatibility with ARDS criteria, and evaluate its potential as a long-lasting research model. Thirty-six male Sprague-Dawley rats were exposed to a 95 % O2 environment. At 24, 48, and 72 h, physiological function, lung histopathology, alveolar-capillary barrier function, and inflammatory response of the model were assessed. Simultaneously, micro-CT was performed to observe lung injury progression and analyze radiomic features. Finally, assisted ventilation experiments were conducted to confirm the model's properties. After 48 h, the oxygenation index of rats significantly decreased (p < 0.0001), reaching mild-moderate ARDS level defined by Berlin criteria. Obvious histological changes occurred (p < 0.0001), with the formation of hyaline membranes, which are uncommon in small rodents. The permeability of the alveolar-capillary was significantly increased (p < 0.0001). The levels of TNF-α, IL-1β, and IL-6 were markedly elevated (p < 0.0001), indicating a strong inflammatory response. Micro-CT revealed diffuse lung injury, with increasing injury severity over prolonged hyperoxia exposure (p < 0.01). Radiomic features analysis revealed imaging changes analogous to those observed in ARDS patients. After 7 days of assisted ventilation experiments, model rats survived, and hypoxemia in the control group persisted. This study established a long-lasting rat model of hyperoxia-induced ARDS that aligns with the criteria for ARDS. The model is reproducible, controllable in severity, long-term stable, and non-resolution in injury. It is expected to serve as an important bridge connecting basic research and clinical translation, and offers a practicable preclinical platform for evaluating novel ventilatory strategies, anti-inflammatory/anti-fibrotic therapeutics, and other interventions.
3. Perinatal outcomes and predictors of neonatal mortality in preterm premature rupture of membranes: a tertiary center experience.
In 183 PPROM cases (23–36+6 weeks), neonatal mortality clustered at the earliest gestations and was associated with lower gestational age, lower birth weight, and oligohydramnios. Early neonatal deaths were predominantly due to RDS, while late deaths were mainly due to sepsis; active management beyond 34 weeks improved outcomes.
Impact: Clarifies gestational-age–stratified risk of neonatal mortality after PPROM and identifies modifiable windows for management, informing perinatal decision-making.
Clinical Implications: Supports aggressive surveillance and timely delivery planning after 34 weeks; emphasizes RDS prevention in early gestations and sepsis prevention for late neonatal period.
Key Findings
- Among 183 PPROM cases, neonatal mortality was highest at 23–27+6 weeks (63.2%), zero in 28–33+6 weeks, and 2.2% at 34–36+6 weeks.
- Risk factors for neonatal mortality included lower gestational age, lower birth weight, and oligohydramnios.
- Early neonatal deaths were mainly due to RDS, whereas late neonatal deaths were primarily due to sepsis.
- Intubated neonates had higher CRP and lower gestational age and birth weight.
Methodological Strengths
- Gestational age stratification with comprehensive neonatal outcome assessment.
- Single-center cohort with consistent management allowing internal comparison.
Limitations
- Retrospective single-center design limits control of confounding and generalizability.
- Small numbers in early gestational strata may yield imprecise estimates.
Future Directions: Prospective multicenter studies to validate predictors and evaluate standardized management protocols, including antenatal steroids, latency antibiotics, and timing of delivery.
BACKGROUND: Preterm premature rupture of membranes (PPROM) is a serious obstetric condition associated with increased maternal, fetal, and neonatal morbidity and mortality. It accounts for approximately one-third of all spontaneous preterm births and is associated with complications such as respiratory distress syndrome (RDS), sepsis, pulmonary hypoplasia, and neonatal mortality. Despite significant advances in prenatal care, proper management, particularly in early gestational age, remains unclear. Identifying factors associated with neonatal mortality in PPROM is important to develop therapeutic interventions and improve perinatal outcomes. METHODS: This retrospective study examined clinical data and neonatal outcomes in 183 pregnant women with PPROM between the gestational ages of 23 and 36 + 6 weeks who were admitted to a tertiary referral hospital. The study population was categorized into four gestational age cohorts: Group I (23-27 + 6 weeks), Group II (28-31 + 6 weeks), Group III (32-33 + 6 weeks), and Group IV (34-36 + 6 weeks). Neonatal outcomes, including admission to the neonatal intensive care unit (NICU), the incidence of respiratory distress syndrome, the requirement for oxygen and mechanical ventilation, the necessity for surfactant and inotropic support, sepsis, suspected pulmonary hypoplasia, and early and late neonatal mortality were compared between the groups. RESULTS: Group I had the highest CRP values (18.68 ± 21.34), while Group III had the lowest (6.81 ± 5.16). Significant differences were found between the groups in terms of death at discharge, gestational age at delivery, birth weight, and presence of oligohydramnios. The intubated group had higher CRP levels and lower gestational age and birth weight. Of the 14 neonatal deaths, eight occurred in the early neonatal period, corresponding to a mortality rate of 7.6%. The neonatal mortality rate was 63.2% in Group I. No deaths were recorded in Groups II and III. In Group IV, the mortality rate was 2.2%. CONCLUSION: Neonatal mortality was associated with low gestational age, low birth weight, and oligohydramnios. The predominant cause of early infant deaths was RDS, whereas late neonatal mortality was primarily attributed to sepsis. Specifically, active management options after 34 weeks of gestational age have demonstrated enhancements in neonatal outcomes, underscoring the significance of tailored clinical approaches in cases of PPROM.